Publication:
Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

Simple item page
dc.contributor.authorAlcalá, Daniel
dc.contributor.authorAcosta, Ana
dc.contributor.authorAndreani, Sebastian
dc.contributor.authorAndriessen, Anneke
dc.contributor.authorCárdenas, Hebert
dc.contributor.authorMoreno, Marcela
dc.contributor.authorMotola, Daniel
dc.contributor.authorRiganti, Julia
dc.contributor.authorOllague, José
dc.contributor.authorLacouture, Mario
dc.contributor.authorToquica, Alejandra
dc.date.accessioned2026-11-03T14:59:14Z
dc.date.available2026-11-03T14:59:14Z
dc.date.issued2025
dc.description.abstractBackground: Cancer-treatment-related cutaneous adverse events (cAEs) are common and may severely impact quality of life (QoL) and decrease treatment outcomes. The Latin American Cutaneous Oncology Management (LACOM) project provides clinical insights into cancer-treatment-related cAEs, offering tools for preventing and managing cAEs. Methods: LACOM I focuses on integrating education, prophylactic measures, and skincare in cancer treatment to improve treatment adherence, outcomes, and patients' and survivors' QoL. Results: The LACOM panel provides evidence and opinion-based best practice recommendations for oncology skincare programs to support all stakeholders in the Latin American healthcare setting (Argentina, Chili, Colombia, Ecuador, Panama, Peru, and Mexico) working with oncology patients throughout the entire continuum of care to achieve optimal outcomes, improving cancer patients and survivors' QoL. Oncology skincare programs comprise hygiene, moisturization, and sun protection with products that should be safe and help to minimize cAEs and improve skin conditions. Conclusions: Integrating education, general measures, and skincare programs into cancer treatment should encourage the adoption of a proactive role of skincare from the beginning of treatment and ongoing, supporting optimal outcomes and improving cancer patients' and survivors' QoL. J Drugs Dermatol. 2025;24(3):262-268. doi:10.36849/JDD.8565.
dc.description.versionVersión Publicada
dc.identifier.citationPérez, D. A., Acosta Madiedo, A. S., Andreani, S., Andriessen, A., Cárdenas, H., Moreno, M., Motola Kuba, D., Riganti, J., Enrique Ollague, J., Lacouture, M., & Toquica, A. (2025). Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors. Journal of drugs in dermatology : JDD, 24(3), 262–268. https://doi.org/10.36849/JDD.8565
dc.identifier.doihttps://doi.org/10.36849/JDD.8565
dc.identifier.urihttps://hdl.handle.net/11447/11310
dc.language.isoen
dc.subjectLatin America / epidemiology
dc.subjectNeoplasms* / drug therapy
dc.subjectPatient Education as Topic / methods
dc.subjectPractice Guidelines as Topic
dc.subjectCancer Survivors
dc.titleLatin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceJournal of drugs in dermatology : JDD
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Latin America Cutaneous Oncology Management (LACOM) I The Role of Skin Care in Oncology Patients and Survivors.pdf
Size:
588.22 KB
Format:
Adobe Portable Document Format
Description:
Texto Completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services